SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Pacetronix submits intimation of receipt of trading approval

22 Jan 2026 Evaluate
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, Shree Pacetronix has informed that BSE vide their letter(s) dated Wednesday, January 21, 2026 having reference no. LOD/PREF/PB/249/2025-2026 have granted trading approval for the trading of 75,150 equity shares of Rs 10 each at an issue price of Rs 81 per share allotted to the promoter on a preferential basis. The approval letter received from the Stock Exchange i.e. BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Shree Pacetronix Share Price

143.34 5.13 (3.71%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 534.85
Poly Medicure 1468.25
Laxmi Denta 195.10
Nureca Ltd. 263.80
Hemant Surgical Inds 297.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×